XML 33 R21.htm IDEA: XBRL DOCUMENT
v3.25.3

Other Expense (Income) | 9 Months Ended
--- | ---
Sep. 30, 2025
Other Income and Expenses [Abstract] |
Other Expense (Income) | Other Expense (Income) Other expense (income) consists of:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
($ in millions) | 2025 |  | 2024 |  | 2025 |  | 2024
Restructuring and related charges | $ | 0.9 |  |  | $ | (2.5) |  |  | $ | 17.5 |  |  | $ | (2.5) |
Contingent consideration | 2.7 |  |  | 1.2 |  |  | 7.3 |  |  | 3.2 |
Foreign exchange transaction losses | 2.7 |  |  | 4.1 |  |  | 5.6 |  |  | 7.3 |
Asset impairments | 0.3 |  |  | 1.0 |  |  | 1.4 |  |  | 1.9 |
Other items | 0.3 |  |  | 0.6 |  |  | 0.9 |  |  | 0.9 |
Total other expense (income) | $ | 6.9 |  |  | $ | 4.4 |  |  | $ | 32.7 |  |  | $ | 10.8 |
Restructuring and Related Charges In January 2025, the Company approved a restructuring plan to adjust our operating cost base to better respond to the macroeconomic factors influencing our business. These changes are expected to be implemented over a period of approximately twenty-four to thirty-six months from the date of approval. The plan is expected to require restructuring and related charges of approximately $30 million to $32 million, with annualized savings in the range of $35 million to $40 million. The following table presents activity related to our restructuring obligations related to our 2025 restructuring plan:
($ in millions) | Severance and benefits |  | Asset-related charges |  |  |  | Total
Balance, December 31, 2024 | $ | — |  |  | $ | — |  |  |  |  | $ | — |
Charges (Credits) | 15.0 |  |  | 2.5 |  |  |  |  | 17.5 |
Cash payments | (7.6) |  |  | — |  |  |  |  | (7.6) |
Non-cash asset write downs | — |  |  | (2.5) |  |  |  |  | (2.5) |
Balance, September 30, 2025 | $ | 7.4 |  |  | $ | — |  |  |  |  | $ | 7.4 |
Contingent Consideration Contingent consideration represents changes in the fair value of the SmartDose® contingent consideration. Please refer to Note 10, Fair Value Measurements, for additional details.

X
- References No definition available. + Details
Name: | us-gaap_OtherIncomeAndExpensesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 720 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/720/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Topic 610 -Publisher FASB -URI https://asc.fasb.org/610/tableOfContent + Details
Name: | us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration